Back

dr. C.T. (Guus) Bol

dr. C.T. (Guus) Bol

Assistant Professor - medical
dr. C.T. (Guus) Bol
  • Onderzoek Medische Oncologie
  • Onderzoek Medische Oncologie

Research Programs

Strategic Program Cancer

Research Output (18)

Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer

van Nassau Sietske C, Bond Marinde J, Scheerman Ilva, van Breeschoten Jesper, Kessels Rob, Valkenburg-van Iersel Liselot B, Verheul Henk M, Buffart Tineke E, Mekenkamp Leonie J, Lemmens Valery E, Koopman Miriam, Bol Guus M, 10 Sep 2021, In: JAMA network open. 4

Welke plaats heeft FOLFOXIRI + bevacizumab bij de behandeling van gemetastaseerd colorectaal carcinoom?

Bond Marinde, Bol Guus, Koopman M, Punt Cornelis JA May 2021, In: Medische Oncologie. 24 , p. 30-31 2 p.

Targeting RNA helicase DDX3 in stem cell maintenance and teratoma formation

Kerr Candace L., Bol Guus M., Vesuna Farhad, Raman Venu Feb 2019, In: Genes & Cancer. 10 , p. 11-20 10 p.

Targeting mitochondrial translation by inhibiting DDX3:A novel radiosensitization strategy for cancer treatment

Heerma Van Voss M. R., Vesuna F., Bol G. M., Afzal J., Tantravedi Saritha, Bergman Y., Kammers Kai, Lehar M., Malek Reem, Ballew M., ter Hoeve N., Abou D., Thorek D., Berlinicke Cynthia, Yazdankhah M., Sinha D., le Couteur A., Abrahams R., Tran Phuoc T., Van Diest P. J., Raman V. 4 Jan 2018, In: Oncogene. 37 , p. 63-74 12 p.

Nuclear DDX3 expression predicts poor outcome in colorectal and breast cancer

Heerma Van Voss Marise R., Vesuna Farhad, Bol Guus M., Meeldijk Jan, Raman Ana, Offerhaus G. Johan, Buerger Horst, Patel Arvind H., Van Der Wall Elsken, Van Diest Paul J., Raman Venu 17 Jul 2017, In: OncoTargets and Therapy. 10 , p. 3501-3513 13 p.

Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer

Heerma van Voss Marise R., Brilliant Justin D., Vesuna Farhad, Bol Guus M., van der Wall Elsken, van Diest Paul J., Raman Venu 1 Mar 2017, In: Medical Oncology. 34

RK-33 radiosensitizes prostate cancer cells by blocking the RNA helicase DDX3

Xie Min, Vesuna Farhad, Tantravedi Saritha, Bol Guus M., Heerma van Voss Marise R, Nugent Katriana, Malek Reem, Gabrielson Kathleen, Van Diest Paul J., Tran Phuoc T., Raman Venu 1 Nov 2016, In: Cancer Research. 76 , p. 6340-6350 11 p.

PLGA nanoparticle formulation of RK-33 an RNA helicase inhibitor against DDX3

Bol Guus Martinus, Khan Raheela, Heerma van Voss Marise Rosa, Tantravedi Saritha, Korz Dorian, Kato Yoshinori, Raman Venu Oct 2016, In: Cancer Chemotherapy and Pharmacology. 76 , p. 821-827 7 p.

FOLFOX chemotherapy as a cause of ventricular septal rupture after alcohol septal ablation for obstructive hypertrophic cardiomyopathy?

Liebregts Max, Bol Guus M., Groen Jan Willem, Lieuw-A-Fa Mariska, Heijmen Robin H., Ten Berg Jurriën M. 15 Mar 2016, In: International Journal of Cardiology. 207 , p. 208-210 3 p.

DDX3, a potential target for cancer treatment

Bol Guus Martinus, Xie Min, Raman Venu 5 Nov 2015, In: Molecular Cancer. 14

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not